课题基金 / 基金详情

CHARACTERIZATION OF NATIVE AND RECOMBINANT ADP-RIBOSYLATION FACTORS

CHARACTERIZATION OF NATIVE AND RECOMBINANT ADP-RIBOSYLATION FACTORS
天然和重组 ADP-核糖化因子的表征
批准号:
3857988
负责人:
S R PRICE
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

S R PRICE的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The ADP-ribosylation factors (ARFs) are 20 kDa guanine nucleotide-binding proteins that were first identified based on their ability to enhance the cholera toxin-catalyzed ADP-ribosylation of Gs-alpha. ARFs isolated from various mammalian tissues had different phospholipid/detergent and nucleotide requirements for activity and stability. Immunological studies using anti-ARF polyclonal antibodies identified membrane and soluble proteins present in all mammalian tissues; the relative amounts of these immunoreactive proteins varied in a tissue-dependent fashion. The fact that six mammalian ARF-like proteins, five human and one bovine, have been identified based on their cDNA and deduced amino acid sequences suggested that different ARFs predominate in different tissues. To investigate whether individual ARFs differ in their requirements for activity, we examined the effects of phospholipids/detergents and GTP concentration on the stimulation of cholera toxin by both native and recombinant ARFs. Although recombinant ARFs expressed in E. coli enhanced the ADP- ribosyltransferase activity of cholera toxin, the requirements for maximal ARF activity and GTP binding were different for the two ARFs. Recombinant ARFs 2 and 6 differed in the concentrations of GTP required for half-maximal activity, the time course for toxin stimulation, and their requirements for phospholipid/detergent. In summary,-these data are consistent with our belief that the relative of specific ARFs differ in different cells and that individual ARFs may have different functions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CHARACTERIZATION OF A HIGHLY CONSERVED 23 KDA BASIC PROTEIN
GENES FOR GTP-BINDING PROTEINS
国内基金
海外基金
asr基因调控酸诱导的Escherichia coli O157:H7形成VBNC状态的机制研究
  • 批准号:
    32302245
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30.00万元
  • 批准年份:
    2023
  • 负责人:
    潘寒姁
  • 依托单位:
小肠中Escherichia coli分泌细菌毒素诱导肠屏障损伤及细菌易位在炎症性肠病中的机制研究
  • 批准号:
    82371775
  • 项目类别:
    面上项目
  • 资助金额:
    46万元
  • 批准年份:
    2023
  • 负责人:
    朱慧媛
  • 依托单位:
基于Escherichia coli O157:H7亚致死态细胞探究超高压与原儿茶酸协同杀菌机制
  • 批准号:
    31871817
  • 项目类别:
    面上项目
  • 资助金额:
    60.0万元
  • 批准年份:
    2018
  • 负责人:
    孙爱东
  • 依托单位:
肠肝轴:从临床患者分离的肠道致病菌株Escherichia coli NF73-1对非酒精性脂肪性肝病的作用及机制研究
  • 批准号:
    81873549
  • 项目类别:
    面上项目
  • 资助金额:
    57.0万元
  • 批准年份:
    2018
  • 负责人:
    刘玉兰
  • 依托单位: